ADORACION B CHAO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHESTER, NJ NPI 1104104462

General Payments — all program years on this page

$1,203.84

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 11
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,189.99 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,189.9910

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $493.224
E.R. Squibb & Sons, L.L.C. $121.651
GlaxoSmithKline, LLC. $120.291
Neurocrine BioSciences, Inc. $119.121
Axsome Therapeutics, Inc. $116.501
Alkermes, Inc. $110.451
ABBVIE INC. $108.761

By program year

Program yearAmountRecords
2023 $13.851
2024 $1,189.9910

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101424732 E.R. Squibb & Sons, L.L.C. $121.65 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104404497 AstraZeneca Pharmaceuticals LP $121.85 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105488239 AstraZeneca Pharmaceuticals LP $123.59 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105551040 AstraZeneca Pharmaceuticals LP $124.98 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105748601 AstraZeneca Pharmaceuticals LP $122.80 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106902256 ABBVIE INC. $108.76 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116469592 GlaxoSmithKline, LLC. $120.29 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120478056 Alkermes, Inc. $110.45 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148330075 Axsome Therapeutics, Inc. $116.50 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150923269 Neurocrine Biosciences, Inc. $119.12 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.